updated Wed. May 29, 2024
-
BBC Three
March 9, 2018
The 17-year-old sat in his GP's office in August 2016, explaining to him everything he knew about the drug. When he and his friends started experimenting with an illegal, counterfeit version of Pfizer-brand Xanax at the beginning of 2016, it was just a fun thing to do at parties – or, occasionally, a way toÃâà...
Equity Bulls
March 1, 2018
Pfizer Inc. had announced on October 10, 2017 that it is reviewing strategic alternatives for its Consumer Healthcare Business. The review will consider a range of options, including a full or partial separation of the Consumer Healthcare business from Pfizer through a spin-off, sale or other transaction, andÃâà...
Times of India
March 1, 2018
"Over time, Pfizer will look to bringing several additional global Pfizer brands to India and globalise the India portfolio," it said. Until the outcome of this review of strategic alternatives is determined, Gelusil, Becosules and Corex will continue to be manufactured and marketed by Pfizer as they are today,Ãâà...
Endpoints News
February 13, 2018
Dex, as it's called, is also sold under Pfizer's brand name Precedex, among other names. BioXcel has started a Phase Ib study using an IV formulation of Dex in mild probable Alzheimer's patients, and plans to start a study in schizophrenia patients in the first half of 2018. The company's other program isÃâà...
FiercePharma
January 12, 2018
Think you saw a lot of TV ads for drugs in 2017? That's because you did. Pharma spending on national TV ads for 2017 climbed even higher than in 2016—by more than $330 million. The total tally was $3.45 billion, compared with $3.11 billion in 2016, according to data from real-time TV tracker iSpot.tv.
FiercePharma
January 3, 2018
Its December total reached almost $31 million spent on nine TV commercials aired nationally across its three indications. Humira was trailed by Bayer and Johnson & Johnson's Xarelto, with Pfizer brands Xeljanz and Lyrica in the third and fourth spots. Pfizer and Bristol-Myers Squibbs' Eliquis rounded outÃâà...
Cincinnati Business Courier
October 26, 2017
P&G has total annual sales of $65 billion, and the Pfizer brands might prove attractive since P&G has indicated it is looking to do more “bolt-on” mergers and acquisitions, Dibadj wrote in a recent note to clients. “We could see some anti-trust concerns in North American sleep aids (such as Pfizer's Advil PMÃâà...
FiercePharma
March 13, 2017
And Pfizer didn't stop there; five of the top nine meds with the highest spending are Pfizer brands. Yet it's likely that AbbVie's Humira beat them all when combining branded spending across indications. Nielsen calculates each Humira ad spend separately for arthritis, colitis/Crohn's disease and psoriasis,Ãâà...
Economic Times
May 13, 2016
MUMBAI: Piramal Enterprises is acquiring four brands of US drug maker Pfizer for Rs 110 crore, the third such acquisition by the Mumbai-based company in the past six months, in line with the strategy to expand its consumer product business. The company, part of Ajay Piramal-led Piramal Group,Ãâà...
|
news and opinion
|